Chemoinformaics analysis of 2-Pyrrolidineacetic acid
| Molecular Weight | 129.159 | nRot | 2 |
| Heavy Atom Molecular Weight | 118.071 | nRig | 6 |
| Exact Molecular Weight | 129.079 | nRing | 1 |
| Solubility: LogS | -0.474 | nHRing | 1 |
| Solubility: LogP | -2.62 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 20.0587 |
| nHD | 2 | BPOL | 12.4733 |
| QED | 0.56 |
| Synth | 2.824 |
| Natural Product Likeliness | 1.153 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.002 |
| HIA | 0.082 |
| CACO-2 | -5.564 |
| MDCK | 0.0000208 |
| BBB | 0.161 |
| PPB | 0.119048 |
| VDSS | 0.824 |
| FU | 0.930063 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.086 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.223 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.293 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.359 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.06 |
| CL | 8.981 |
| T12 | 0.584 |
| hERG | 0.022 |
| Ames | 0.046 |
| ROA | 0.168 |
| SkinSen | 0.537 |
| Carcinogencity | 0.625 |
| EI | 0.555 |
| Respiratory | 0.499 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.932206 |